EVO vs. MDT
EVO (Evotec SE ADR) and MDT (Medtronic plc) are both stocks. Both are in the Healthcare sector — EVO in Drug Manufacturers - Specialty & Generic, MDT in Medical Devices. Over the past 10 years, EVO returned -1.89%/yr vs 2.43%/yr for MDT. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
EVO vs. MDT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EVO achieves a -37.99% return, which is significantly lower than MDT's -9.57% return. Over the past 10 years, EVO has underperformed MDT with an annualized return of -1.89%, while MDT has yielded a comparatively higher 2.43% annualized return.
EVO
- 1D
- -1.04%
- 1M
- -34.14%
- 6M
- -47.67%
- YTD
- -37.99%
- 1Y
- -52.49%
- 3Y*
- -47.31%
- 5Y*
- -37.73%
- 10Y*
- -1.89%
- ALL TIME*
- 1.16%
MDT
- 1D
- -0.37%
- 1M
- 2.64%
- 6M
- -15.63%
- YTD
- -9.57%
- 1Y
- -1.31%
- 3Y*
- 2.43%
- 5Y*
- -5.33%
- 10Y*
- 2.43%
- ALL TIME*
- 13.29%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $102.03K | $137.11K | $133.87K | |
| $617.64M | $644.39M | $789.93M |
EVO vs. MDT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EVO Evotec SE ADR | -37.99% | -25.96% | -64.54% | 44.99% | -65.94% | 29.45% | 42.78% | 29.05% | 24.08% | 106.17% |
MDT Medtronic plc | -9.57% | 24.05% | 0.28% | 9.58% | -22.55% | -9.79% | 5.70% | 27.34% | 15.18% | 15.90% |
Correlation
The correlation between EVO and MDT is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.21 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Dec 4, 2009 | 0.17 |
Fundamentals
EVO:
$678.51M
MDT:
$109.30B
EVO:
-€0.29
MDT:
$3.73
EVO:
0.75
MDT:
3.02
EVO:
0.72
MDT:
2.22
EVO:
€786.00M
MDT:
$36.36B
EVO:
€113.49M
MDT:
$23.64B
EVO:
-€34.87M
MDT:
$9.72B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EVO vs. MDT — Risk / Return Rank
EVO
MDT
EVO vs. MDT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Evotec SE ADR (EVO) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EVO | MDT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.87 | ||
| Sortino ratioReturn per unit of downside risk | -1.43 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 1.00 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | -0.08 | -0.89 |
| Martin ratioReturn relative to average drawdown | -1.97 | -0.17 | -1.80 |
Loading charts...
Drawdowns
EVO vs. MDT - Drawdown Comparison
The maximum EVO drawdown since its inception was -92.80%, which is greater than MDT's maximum drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for EVO and MDT.
Loading charts...
Drawdown Indicators
| EVO | MDT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.80% | -57.63% | -35.17% |
Max Drawdown (1Y)Largest decline over 1 year | -53.98% | -28.90% | -25.08% |
Max Drawdown (3Y)Largest decline over 3 years | -84.91% | -28.90% | -56.01% |
Max Drawdown (5Y)Largest decline over 5 years | -92.80% | -45.10% | -47.70% |
Max Drawdown (10Y)Largest decline over 10 years | -92.80% | -45.10% | -47.70% |
Current DrawdownCurrent decline from peak | -92.80% | -26.11% | -66.69% |
Average DrawdownAverage peak-to-trough decline | -34.26% | -16.58% | -17.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.47% | 13.67% | +12.80% |
Volatility
EVO vs. MDT - Volatility Comparison
Evotec SE ADR (EVO) has a higher volatility of 19.51% compared to Medtronic plc (MDT) at 9.97%. This indicates that EVO's price experiences larger fluctuations and is considered to be riskier than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EVO | MDT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.51% | 9.97% | +9.54% |
Volatility (6M)Calculated over the trailing 6-month period | 43.49% | 19.10% | +24.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.17% | 23.57% | +30.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 59.31% | 22.40% | +36.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.99% | 23.47% | +28.52% |
Dividends
EVO vs. MDT - Dividend Comparison
EVO has not paid dividends to shareholders, while MDT's dividend yield for the trailing twelve months is around 3.34%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVO Evotec SE ADR | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MDT Medtronic plc | 3.34% | 2.95% | 3.49% | 3.34% | 3.44% | 2.39% | 1.95% | 1.87% | 2.15% | 2.24% | 2.34% | 1.88% |
Financials
EVO vs. MDT - Financials Comparison
This section allows you to compare key financial metrics between Evotec SE ADR and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EVO vs. MDT - Profitability Comparison
EVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Evotec SE ADR reported a gross profit of 77.73M and revenue of 250.90M. Therefore, the gross margin over that period was 31.0%.
MDT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Medtronic plc reported a gross profit of 7.44B and revenue of 9.81B. Therefore, the gross margin over that period was 75.9%.
EVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Evotec SE ADR reported an operating income of 24.06M and revenue of 250.90M, resulting in an operating margin of 9.6%.
MDT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Medtronic plc reported an operating income of 1.56B and revenue of 9.81B, resulting in an operating margin of 16.0%.
EVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Evotec SE ADR reported a net income of 14.49M and revenue of 250.90M, resulting in a net margin of 5.8%.
MDT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Medtronic plc reported a net income of 1.24B and revenue of 9.81B, resulting in a net margin of 12.7%.
Frequently Asked Questions
EVO and MDT have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EVO has higher volatility (19.51%) compared to MDT (9.97%). In terms of maximum drawdown, EVO dropped -92.80% vs MDT's -57.63%.
MDT currently has the higher Sharpe Ratio (-0.10 vs -0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EVO and MDT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer